Project description
Capturing the patient perspective for development of new cancer therapies
Patient-reported outcomes (PROs) are used in cancer clinical trials to determine the impact of a medical treatment or intervention. As such, PROs and health-related quality of life quantifying how a patient feels or functions during treatment are important endpoints. However, the various ways with which these measures are currently analysed and interpreted make it difficult to compare results across trials. In this context, the EU-funded SISAQOL-IMI project will work to standardise methods to analyse valid PRO objectives and ways to communicate these findings. Specifically, it will identify valid PRO research objectives and match these with appropriate statistical methods for PRO analysis in controlled randomised trials.
Fields of science
Programme(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
Participants (32)
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
31008 Pamplona
SE1 0SW London